Karen Reeves, M.D.
About Karen Reeves, M.D.
Karen Reeves, M.D. - Title and Current Position
Karen Reeves, M.D., holds the position of Senior Vice President of Clinical Strategy and Investments. Her role involves strategic oversight and direction in the clinical field and investment functionalities within her organization.
Karen Reeves, M.D. - Education and Expertise
Karen Reeves earned her B.A. from Yale University and proceeded to obtain her M.D. from the University of Vermont Medical School. Her expertise is fortified by faculty roles at prominent institutions such as Harvard Medical School and Tufts University School of Medicine. These academic positions have contributed to her depth of knowledge in medical and clinical sciences.
Karen Reeves, M.D. - Professional Background
Karen Reeves has an extensive professional background in the pharmaceutical industry. She previously served as President and Chief Medical Officer at AZTherapies, Inc., where she spearheaded medical initiatives. Additionally, she held multiple leadership roles at Pfizer Inc., including Vice President, Worldwide Research and Development. Her experience extends to Astellas Pharma Inc., where she acted as Vice President and Head of Global Medical Science, overseeing global medical physicians across various therapeutic areas.
Karen Reeves, M.D. - Achievements in Drug Development
Karen Reeves has a distinguished record in drug development. She was instrumental in the development and approval of three marketed drugs in the neuroscience field. Moreover, her leadership as the team lead for the Prix Galien Award-winning pharmaceutical, CHANTIX, highlights her significant contributions to medical science.
Karen Reeves, M.D. - Contribution to Federal Funding for NIH/US DHHS ARPA-H
As part of her collaborative efforts, Karen Reeves played a role in a documentary that helped secure $2.5 billion in federal funding for the NIH/US DHHS ARPA-H. This emphasis on advocacy and resource mobilization underscores her influential presence in the field.